About Admera
Admera is a company based in South Plainfield (United States) founded in 2014. The company has 27 employees. Admera operates in a competitive market with competitors including Denali Therapeutics, GRAIL, MiRagen, Color and Juno Therapeutics, among others.
- Headquarter South Plainfield, United States
- Employees 27
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website admerahealth.com
- Social LinkedIn
- Legal Name Admera Health Llc
- InvestorsBioVenture
& 2 more
- Employee Count27
Funding Insights of Admera
- Total Rounds 1
- Investors Count 3
All 1 funding rounds of Admera with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2015 | – | Series A | – | Prime Value Capital Managment |
3 investors in total: 3 institutional.
Investors in Admera
Admera has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include BioVenture, PVCM and Himile Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
BioVenture is focused on early and growth-stage healthcare investments. | 2013 | bioventure.com.cn | Suzhou, China | |
Value investing services are provided to clients globally by PVCM. | 2009 | pvcm.ie | Blackrock, Ireland | |
- | – | himilecapital.com | - |
Investor details for Admera
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Admera
17 people are tracked at Admera (7 in leadership, 10 in team); the tracked headcount is 27.
| Name | Role | Group |
|---|---|---|
Yanqiong Zhang | Director, Business Consulting | Leadership |
Yun Zhao | CEO & Board Member | Leadership |
yingying liu | Senior Director | Leadership |
Yulys Linguanti | Associate Director of Accounting | Leadership |
Min Wei, PhD | Head of Clinical Services | Leadership |
Amanda Raywood | Director Of Human Resources | Leadership |
Grace Box | Associate Director of Project Management | Leadership |
MILTON Sanabria | Project Specialist - PM (biopharma Services) | Team |
Junjiang Shen | Senior Sales Executive | Team |
Kristen Tummillo | Scientist II, Team Lead | Team |
Carly Vodola | Senior Associate Scientist I, Team Lead | Team |
Yaping Feng | Bioinformatics manager | Team |
Xinjun He | Manager of Research and Development | Team |
Theresa Chia-yu Kung | Scientist II, Team Lead | Team |
Atrayee C. | Associate Project Specialist II | Team |
Shannon Piehl | Senior Sales Executive | Team |
Janelle R. | Senior Project Specialist I, Team Lead | Team |
Complete people profiles for Admera
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Admera
2 dated milestones of Admera across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Admera is founded.
- Funding First funding round.
Competitors of Admera
Admera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, GRAIL, MiRagen, Color and Juno Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| denalitherapeutics.com | 2015 | San Francisco, United States | $347M | 377 | Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's. | |
| grail.com | 2016 | Menlo Park, United States | $3.22B | 491 | Circulating tumor DNA is screened for early cancer detection. | |
| miragen.com | 2007 | Boulder, United States | $111.29M | 92 | MicroRNA-based therapeutics are developed for treating multiple diseases. | |
| color.com | 2013 | Burlingame, United States | $506.44M | 687 | Cancer care is delivered through a virtual clinic by Color. | |
| junotherapeutics.com | 2013 | Seattle, United States | $316.67M | 520 | CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | |
| cernostics.com | 2008 | Pittsburgh, United States | $14.18M | 16 | Precision diagnostic and prognostic tests are developed by Castle Biosciences. | |
| prenetics.com | 2009 | Hong Kong, China | $67.65M | – | Health risks are identified through online genetic and diagnostic testing. | |
| unitybiotechnology.com | 2016 | San Francisco, United States | $206M | – | Therapeutics for aging diseases are developed by targeting senescent cells. |
Detailed competitors of Admera
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Admera
The website of Admera (admerahealth.com) receives about 6.6K visits a month and ranks #3,477,831 among all websites worldwide, #4,514 in Biotechnology and Pharmaceuticals.
- Monthly visits6.6K
▲ 26.9% vs previous month
- Unique visitors2.2K
per month
- Global rank#3,477,831
among all websites
- Category rank#4,514
Health · Biotechnology and Pharmaceuticals
- Bounce rate44%
- Pages per visit2.0
- Average visit1 min 21 sec
- DevicesDesktop 49% · Mobile 51%
Websites whose visitors overlap most with Admera. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| berrygenomics.com | 100% | 35.4K | #787,850 | View details | |
| dnacomplete.com | 57% | 114.8K | #341,281 | View details | |
| lifedna.com | 40% | 116.1K | #291,657 | View details |
Latest news on Admera
Complete news archive for Admera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Admera
10 companies that operate in the same segment as Admera (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Admera
Admera was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Admera is headquartered in South Plainfield, United States. It is registered at South Plainfield, New Jersey, United States.
Admera has 27 employees.
Provider of a portfolio of genetic tests for precision medicine. The company offers a suite of high-integrity pharmacogenomics (PGx) solutions, diagnostic testing, and biopharmaceutical research services. The product line includes PGxOne Plus pharmacogenomics (PGx) test, OncoGxOne for detecting driver mutations and immunotherapy biomarkers in solid tumors, AtheroGxOne, and CardioGxOne to detect cardiovascular diseases.
Admera's top competitors include GRAIL, Juno Therapeutics and Prenetics.
Admera has 3 investors. Key investors include BioVenture, PVCM, and Himile Capital Management.
Admera operates through Admera Health Llc.